Registration statement for securities of certain foreign private issuers

Segment Information (Tables)

v3.22.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure of operating segments [abstract]  
Schedule of Consolidated Statements of Profit and Loss

Below is a summary of the Group’s segments and a reconciliation between the results from operations as per segment information and the results from operations as per the Consolidated Statements of Profit and Loss.

For the Year Ended December 31, 2021

Total as

per

statement

All other

Total

Reconciliation

of profit

UK

US

segments

segments

adjustments

and loss

$’000

$’000

$’000

$’000

$’000

$’000

Revenue

88,967

232,296

1,610

322,873

48

322,921

Inter-segment revenue

2,205

(3,964)

1,756

(3)

3

0

Segment revenue

91,172

228,332

3,366

322,870

51

322,921

Cost of care delivery

(41,542)

(253,998)

(1,590)

(297,130)

7,458

(289,672)

Other operating expenses, excluding amortization and depreciation

(114,975)

(105,602)

(171,951)

(392,528)

(8,226)

(400,754)

Change in fair value of warrant liabilities

27,811

27,811

27,811

Exchange (loss) / gain

(1,844)

189

1,390

(265)

1,133

868

Gain on sale of subsidiary

2,687

2,687

1,230

3,917

Gain on remeasurement of equity interest

10,495

10,495

10,495

Share of loss of equity-accounted investees

(2,602)

(2,602)

(2,602)

Segment EBITDA

(67,189)

(133,681)

(127,792)

(328,662)

1,646

(327,016)

Depreciation and amortization

  

  

  

  

(35,004)

Change in fair value of warrant liabilities

  

  

  

  

(27,811)

Exchange gain

  

  

  

  

(868)

Gain on sale of subsidiary

  

  

  

  

(3,917)

Gain on remeasurement of equity interest

  

  

  

  

(10,495)

Share of loss of equity-accounted investees

  

  

  

  

2,602

Operating loss

  

  

  

  

(402,509)

For the Year Ended December 31, 2020

Total as

per

statement

All other

Total

Reconciliation

of profit

UK

US

segments

segments

adjustments

and loss

$’000

$’000

$’000

$’000

$’000

$’000

Revenue

44,000

32,226

2,968

79,194

78

79,272

Inter-segment revenue

 

1,194

 

(3,094)

 

1,766

 

(134)

 

134

 

0

Segment revenue

 

45,194

 

29,132

 

4,734

 

79,060

 

212

 

79,272

Cost of care delivery

 

(34,600)

 

(34,381)

 

(7,205)

 

(76,186)

 

8,932

 

(67,254)

Other operating expenses, excluding amortization and depreciation

 

(127,762)

 

(27,190)

 

(3,990)

 

(158,942)

 

(14,100)

 

(173,042)

Exchange (loss) / gain

 

403

 

(246)

 

17,060

 

17,217

 

(20,053)

 

(2,836)

Share of loss of equity-accounted investees

 

 

 

(1,124)

 

(1,124)

 

 

(1,124)

Segment EBITDA

 

(116,765)

 

(32,685)

 

9,475

 

(139,975)

 

(25,009)

 

(164,984)

Depreciation and amortization

 

 

  

 

  

 

  

 

  

 

(14,487)

Exchange loss

 

 

  

 

  

 

  

 

  

 

2,836

Share of loss of equity-accounted investees

 

 

  

 

  

 

  

 

  

 

1,124

Operating loss

 

 

  

 

  

 

  

 

  

 

(175,511)

For the Year Ended December 31, 2019

Total as

per

statement

All other

Total

Reconciliation

of profit

UK

US

segments

segments

adjustments

and loss

$’000

$’000

$’000

$’000

$’000

$’000

External revenue

14,633

1,410

16,043

(9)

16,034

Inter-segment revenue

4,081

(2,669)

(1,382)

30

(30)

Segment revenue

18,714

(2,669)

28

16,073

(39)

16,034

Cost of care delivery

(25,707)

(160)

(373)

(26,240)

6,430

(19,810)

Other operating expenses, excluding amortization and depreciation

(119,895)

(23,273)

(5,340)

(148,508)

(8,040)

(156,548)

Exchange (loss) / gain

 

314

 

(83)

 

16,584

 

16,815

 

260

 

17,075

Segment EBITDA

 

(126,574)

 

(26,185)

 

10,899

 

(141,860)

 

(1,389)

 

(143,249)

Depreciation and amortization

 

 

  

 

  

 

  

 

  

 

(2,496)

Exchange gain

 

 

  

 

  

 

  

 

  

 

(17,075)

Operating loss

 

 

  

 

  

 

  

 

  

 

(162,820)

Disaggregation of Revenue

Below is a summary of the revenue derived from the Group’s major customers:

    

For the Year Ended December 31,

 

2021

2020

2019

 

$‘000

% of revenue

$‘000

% of revenue

$‘000

% of revenue

 

Customer 1

119,785

37.1

%  

11,918

15.0

%  

2,215

13.8

%

Customer 2

 

39,764

 

12.3

%  

9,706

 

12.3

%  

2,465

 

15.4

%

Customer 3

 

38,705

 

12.0

%  

9,505

 

12.0

%  

5,607

 

34.9

%

Customer 4

 

N/A

 

N/A

 

14,937

 

18.9

%  

N/A

 

N/A

Geographical Information

Revenue from external customers attributed to individual countries is summarized as follows:

    

For the Year Ended December 31,

2021

2020

2019

$’000

$’000

$’000

UK

35,490

28,827

12,189

US

 

232,708

 

32,689

 

Asia-Pacific

 

14,965

 

11,585

 

2,215

Canada

 

38,705

 

3,207

 

564

Rest of World

 

1,053

 

2,964

 

1,066

Total

 

322,921

 

79,272

 

16,034